HLA alleles associated to susceptibility to gliptin‐associated bullous pemphigoid in Italian patients
HLA · 2024-08 · 104 (2)
DOI: 10.1111/tan.15616 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, online erschienen am 02.08.2024. Verfasst von Marco Andreani und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratorio di Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy. Hauptthemen laut MEDLINE: Pemphigoid, Bullous, Genetic Predisposition to Disease, Alleles, Haplotypes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Italian Ministry of Health, Ministero della Salute.
Abstract (Originalsprache)
Bullous pemphigoid (BP), although a rare disease, is the most frequent subepidermal autoimmune disorder. Treatment with gliptins, used for type 2 diabetes, was reported as associated with BP onset. To identify HLA alleles that may reflect a higher susceptibility to BP in the Italian population, we analysed 30 patients affected by idiopathic bullous pemphigoid (IBP) and 86 gliptin‐associated BP (GABP) patients. A significant association between HLA‐DQB1*03:01 allele and IBP and GABP patients was found. Of note, both IBP and GABP were significantly associated with one of the following haplotypes: DRB1*11:01 , DRB3*02:02 , DQA1*05:05 , DQB1*03:01 or DRB1*11:04 , DRB3*02:02 , DQA1*05:05 and DQB1*03:01 . These data identify, for the first time, potential markers of susceptibility to BP in the Italian population, especially when associated with gliptin intake.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratorio di Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
- Molecular and Cell Biology Laboratory, Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Rome, Italy.
- Università Cattolica del Sacro Cuore, Rome, Italy.
- Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica, IRCCS Ospedale Pediatrico Bambino Gesù, Rome, Italy.
- Dermatology Unit, National Institute for Infectious Diseases IRCCS - L. Spallanzani, Rome, Italy.
- Laboratory of Cutaneous Physiopathology and Integrated Center for Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Rome, Italy.
ORCID-Profile: Marco Andreani, Mariarosa Battarra, Barbara Bellei
Förderung
- Italian Ministry of Health
- Ministero della Salute
Zitieren
APA
Andreani, M., Mariotti, F., Pira, A., Locatelli, F., Testa, G., Battarra, M., Caputi, P., Scarabello, A., Bellei, B., Di Campli, C., Collina, M. C., Esposito, I., Giampetruzzi, A. R., Didona, B., Pitocco, D., De Simone, C., & Di Zenzo, G. (2024). HLA alleles associated to susceptibility to gliptin‐associated bullous pemphigoid in Italian patients. HLA, 104(2). https://doi.org/10.1111/tan.15616
Vancouver
Andreani M, Mariotti F, Pira A, Locatelli F, Testa G, Battarra M, et al. HLA alleles associated to susceptibility to gliptin‐associated bullous pemphigoid in Italian patients. HLA. 2024;104(2). doi:10.1111/tan.15616
BibTeX
@article{Andreani2024,
author = {Andreani, Marco and Mariotti, Feliciana and Pira, Anna and Locatelli, Franco and Testa, Giuseppe and Battarra, Mariarosa and Caputi, Priscilla and Scarabello, Alessandra and Bellei, Barbara and Di Campli, Cristiana and Collina, Maria Chiara and Esposito, Ilaria and Giampetruzzi, Anna Rita and Didona, Biagio and Pitocco, Dario and De Simone, Clara and Di Zenzo, Giovanni},
title = {HLA alleles associated to susceptibility to gliptin‐associated bullous pemphigoid in Italian patients},
journal = {HLA},
year = {2024},
volume = {104},
number = {2},
doi = {10.1111/tan.15616}
}
EUVIMED